WILLIAM ADAMS: Open Payments
NPI 1467403733 · RIGBY, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$502 in 28 payments from 13 companies in 2025. Trend: 2023 $362 · 2024 $597 · 2025 $502
Food & beverage: $502
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $155 |
| Lilly USA, LLC | 4 | $62 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Astellas Pharma US Inc | 1 | $34 |
| PFIZER INC. | 2 | $32 |
| Phathom Pharmaceuticals, Inc. | 2 | $30 |
| Boston Scientific Corporation | 1 | $30 |
| Exact Sciences Corporation | 1 | $27 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
Products named: VRAYLAR, MOUNJARO, UBRELVY, REXULTI, Veozah, NURTEC ODT, VOQUEZNA, General - Pain Management.
Industry payments across ID — which companies pay providers there.
